{"id":"W2100615084","doi":"10.1111/j.1365-2265.2009.03620.x","title":"A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long‐acting octreotide in patients with acromegaly","year":2009,"lang":"en","type":"article","venue":"Clinical Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk; National Institutes of Health; Pfizer; Eli Lilly and Company","keywords":"Pegvisomant; Medicine; Acromegaly; Adverse effect; Internal medicine; Octreotide; Randomized controlled trial; Gastroenterology; Somatostatin; Endocrinology; Growth hormone; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003052505,0.0002480489,0.002358255,0.0001559224,0.0000520665,0.00001083425,0.00006858011,0.00008279849,0.00001644822],"category_scores_gemma":[0.000354426,0.0001411418,0.000179493,0.00009998305,0.000276905,0.00008729125,0.00002337117,0.0002838704,0.00000333716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002446413,"about_ca_system_score_gemma":0.00005911614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001099696,"about_ca_topic_score_gemma":0.0001233916,"domain_scores_codex":[0.9976823,0.0003174676,0.001011415,0.0003938795,0.0002156726,0.0003792408],"domain_scores_gemma":[0.9980978,0.0009874346,0.0004457322,0.0002284038,0.000119758,0.0001209108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5258127,0.003108055,0.4656512,0.000008205539,0.0003168824,0.00009170965,0.00007167459,0.000004143225,8.535438e-7,0.0001131429,0.000002267328,0.004819175],"study_design_scores_gemma":[0.5765839,0.004969073,0.4176741,0.00006573311,0.000166245,0.00001381934,0.00004428526,0.0003074204,0.000007359578,0.0000777518,0.000006922835,0.0000833833],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994734,0.0006043029,0.00005690918,0.0005410887,0.00009052169,0.003291011,0.000002028864,0.00002971384,0.0006504275],"genre_scores_gemma":[0.9987971,0.0005638602,0.0002388085,0.0002103676,0.000033091,0.00005348982,0.00004253236,0.00001355769,0.00004721456],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05077122,"threshold_uncertainty_score":0.5755594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02594826122174928,"score_gpt":0.3208575987697698,"score_spread":0.2949093375480205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}